89bio, Inc. Common Stock logo

ETNB Q2 2025 Earnings Results — 89bio, Inc. Common Stock

XNAS · Healthcare · Biotechnology

Updated

Price $14.95
Market Cap $2.2B
P/E —
52W Range $4.16 – $15.06

When is ETNB's next earnings date?

89bio, Inc. Common Stock (ETNB) has not announced its next earnings date yet. Its most recent earnings report was on Thursday, August 7, 2025.

How did ETNB do in its last earnings report?

In its most recent report on Aug 7, 2025 (Q2 2025), 89bio, Inc. Common Stock posted EPS of -$0.71 versus the -$0.49 estimate, a miss of 44.9%. Revenue was $0. The stock's 1-day post-earnings move was +1.6%.

How much does ETNB stock move after earnings?

ETNB beat EPS estimates in 3 of its last 8 reported quarters. Over the last 6 reports the stock moved an average of 4.7% (up or down) in the day after earnings.

About 89bio, Inc. Common Stock

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2025-08-07Q2 2025-0.49-0.71-44.90%$0❌ Miss+1.61%+0.89%-4.99%
2025-02-27Q4 2024-0.73-1.02-39.73%$0❌ Miss-0.97%-10.84%-13.30%
2024-11-07Q3 2024-0.64-1.39-117.19%$0❌ Miss+4.92%-12.15%-19.38%
2024-02-29Q4 2023-0.49-0.50-2.04%$0❌ Miss+10.03%+13.51%-6.45%
2023-11-08Q3 2023-0.53-0.45+15.09%$0✅ Beat-4.86%-5.23%+22.79%
2023-03-10Q4 2022-0.69-0.48+30.43%$0✅ Beat-5.96%-0.86%+12.93%
2022-11-10-0.80-0.57——✅ Beat———
2022-08-11-1.05-1.23——❌ Miss———

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .